Bolt Biotherapeutics, Inc. Common Stock (BOLT) is a publicly traded Healthcare sector company. As of August 11, 2026, BOLT trades at $3.83 with a market cap of $7.67M and a P/E ratio of -0.24. BOLT moved +0.00% today. Year to date, BOLT is -27.21%; over the trailing twelve months it is -29.35%. Its 52-week range spans $3.75 to $12.60. Analyst consensus is strong buy with an average price target of $34.67. Rallies surfaces BOLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BOLT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $3.83 |
| Market Cap | $7.67M |
| P/E Ratio | -0.24 |
| EPS | $-16.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.60 |
| 52-Week Low | $3.75 |
| Volume | 5.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.50M |
| Net Income | $-29.58M |
| Gross Margin | 0.00% |
4 analysts cover BOLT: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.67.